pexels pixabay 159027

Car-T cell therapy, looking beyond the hype!

While CAR-Ts have already demonstrated convincing efficacy in a specific setting, the jury is still out on whether they are a ‘game-changer’ for oncology as a whole and can justify current valuations and investor interest.

Discover Other Articles

Discover Other Articles